Board meeting scheduled for May 5, 2026 to approve audited standalone and consolidated financial results for Q4 and year ended March 31, 2026.
Board to consider recommendation of final dividend for financial year 2025-26, if any.
Trading window closed from April 15, 2026 to May 7, 2026 due to unpublished price sensitive information.